In a similarly designed study, Pailler et al. [22] described high concordance in ALK rearrangement patterns between the CTC and tumor biopsies in 18 ALK-positive and 14 ALK-negative patients with metastatic NSCLC. The gene discussed is ALK; the disease is non-small cell lung carcinoma.